Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Type 2 Diabetes in Adults With Sickle Cell Disease: Can we Dive Deeper? Response to Skinner et al
source: British Journal of Haematology
year: 2019
authors: Jifang Zhou, Jin Han, Edith A. Nutescu, William L. Galanter, Surrey M. Walton, Victor R. Gordeuk, Santosh L. Saraf, Gregory S. Calip
summary/abstract:We read with interest the letter from Skinner, Nader and Connes and their comments on our recently published study on the burden of type 2 diabetes (T2D) in patients with sickle cell disease (SCD). The authors call attention to variation in T2D risk across patients with different SCD genotypes. Despite the fact that SCD is caused by single gene disorders, patients with SCD demonstrate a complex spectrum of complications and phenotypic heterogeneity that can be partially explained by the variability of fetal haemoglobin levels and co‐inheritance of alpha thalassaemia. It is plausible to speculate that SCD patients of different genetic foundation could present distinct pathophysiology features, including lipid profile and anthropometrics, which in turn could influence the likelihood of being diagnosed with T2D.
To answer the questions raised by Dr. Skinner and colleagues, we must acknowledge the inherent limitations of administrative health databases in performing studies of disease burden. Herein we describe the challenges of further exploration of these currently available data and the necessary methodological considerations for such epidemiological studies, particularly possible information and selection biases.
organization: University of Illinois at Chicago, USA; Fred Hutchinson Cancer Research Center, USADOI: 10.1111/bjh.15949
read more
+myBinderRelated Content
-
Sickle Cell Disease: The Evil Spirit of Misshapen HemoglobinSickle cell disease (SCD) is the most co...
-
Sickle Cell DiseaseSickle cell disease is an inherited (pas...
-
Darryl Watkins Stays Positive in Spite of Sickle Cell DiseaseDarryl Watkins has the HbSS variant of s...
-
Study challenges view that sickle cell trait increases mortality riskSurprising findings from a study of heal...
-
La Jolla Pharmaceutical company announces initiation of pivotal clinical study of LJPC-401 in patients with beta tha...La Jolla Pharmaceutical company today an...
-
Ty Montgomery says he’s not worried about sickle cell traitThe symptoms that kept Ty Montgomery out...
-
Mental Health and Wellness Services for Persons Diagnosed With Sickle Cell Disease in CaliforniaWhat Is the New CA Sickle Cell Disease (...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.